… The aim of this paper is to review the evidence regarding when to switch antidepressants and
… Early switching strategies in antidepressant non-responders: current evidence and future …

… In conclusion, rTMS should be considered as a viable treatment option at an early stage of
the treatment algorithm and may be more effective than antidepressant medication switch or …

… -approved augmentation versus switch strategies to employ. Our … The present study is the
first randomized effectiveness study to … Future studies comparing rTMS augmentation with other …

… , switching will make clinical sense when early improvements … of antidepressant, other than
the one used in the first instance, … avoid abandoning treatments and therefore future relapses. …

… early non-responders to sertraline (≤20% reduction in MADRS within the first 2 weeks),
randomisation to paroxetine switching (n =… Future trials may investigate mechanisms potentially …

… An open-label study in 192 patients without improvement after 2 weeks of initial escitalopram
compared a two-step early change/augmentation strategy (non-responders 4 weeks after …

… reviewing the evidence (… early switching strategies) for the predictive value of early
improvement at 2–4 weeks to predict final antidepressant response concluded that lack of early …

… This article aims to summarize the current evidence-based treatment options concerning …
Early switching strategies in antidepressant non-responders: current evidence and future …

… support for other strategies such as combining or switching antidepressants. In the future,
more studies … First, we review the evidence for four individual options: increasing AD dosage, …

… This review highlights the importance of early response as a … one antidepressant treatment
failure in their current depressive … discussed, we propose that future work should focus on the …